Igmesine hydrochloride

Drugs of the Future

Volumn 24, Issue 2, 1999, Pages 133-140

  Sorbera, L A ^a   Silvestre, J ^a   Castaner J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3,4 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE; 4 (4 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 [4 (1,2,4 TRIAZOL 1 YL)BUTYL]PYRIDINE; AMIODARONE; ANTIDEPRESSANT AGENT; ANTIDIARRHEAL AGENT; AZ 21666; AZIDOPAMIL; HALOPERIDOL; IGMESINE; L 687384; LU 28 179; N ALLYLNORMETAZOCINE; PENTAZOCINE; PRECLAMOL; PROGESTERONE; RIMCAZOLE; SIGMA RECEPTOR LIGAND; TRIFLUOPERAZINE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DRUG ACTIVITY; DRUG INDICATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; NONHUMAN; RECEPTOR AFFINITY;

EID: 0032936187     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1999.024.02.474038     Document Type: Article

References (63)

1. Aubard, G., Calvet, A., Gouret, C., Grouhel, A., Jacobelli, H., Junien, J.-L. (Jouveinal SA). Disubstituted benzylamines, process for their preparation, their use as medicament and their synthesis intermediates. EP 361990, EP 362001, FR 2636625, US 5034419, US 5089639.
2. Martin, W.R., Eades, C.G., Thompson, J.A., Huppler, R.E., Gilbert, P.E. The effects of morphine-and nalmorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976, 197: 517-32.
3. Tam, S.W. Naloxone-inaccessible sigma receptor in rat central nervous system. Proc Natl Acad Sci USA 1983, 80: 6703-7.
4. Vaupel, D.B. Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog. Eur J Pharmacol 1983, 92: 269-74.
5. Chavkin, C. The σ enigma: Biochemical and functional correlates emerge for the haloperidol-sensitive binding site. Trends Pharmacol Sci 1990, 11: 213-5.
6. 3H]SKF-10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J Pharmacol Exp Ther 1986, 238: 739-48.
7. Sonders, M.S., Keana, J.F.W., Weber, E. Phencyclidine and psychotomimetic σ opiates: Recent insights into their biochemical and physiological sites of action. Trends Neurosci 1988, 11: 37-40.
8. Walker, J.M., Bowen, W.D., Walker, F.P., Matsumoto, R.R., De Costa, B., Rice, K.C. Sigma receptors: Biology and function. Pharmacol Rev 1990, 42: 355-402.
9. 3H]SKF 10,047 binding sites in rat liver. Eur J Pharmacol 1988, 147: 259-64.
10. Roman, F., Pascaud, X., Vauche, D., Junien, J.L. Evidence for a non-opioid σ binding site in the guinea-pig myenteric plexus. Life Sci 1988, 42: 2217-22.
11. Roman, F., Pascaud, X., Chomette, G., Bueno, L., Junien, J.L. Autoradiographic localization of a opioid receptors in the gastrointestinal tract of the guinea pig. Gastroenterology 1989, 97: 76-82.
12. Wolfe, S.A. Jr., Ha, B.K., Whitlock, B.B., Saini, P. Differential localization of three distinct binding sites for a receptor ligands in rat spleen. J Neuroimmunol 1997, 72: 45-58.
13. Wolfe, S.A. Jr., Kulsakdinum, C., Battaglia, G., Jaffe, J.H., De Souza, E.B. Initial identification and characterization of σ receptors on human peripheral blood leukocytes. J Pharmacol Exp Ther 1988, 247: 1114-9.
14. Itzhak, Y., Stein, I. Sigma binding sites in the brain: An emerging concept of multiple sites and their relevance for psychiatric disorders. Life Sci 1990, 47: 1073-81.
15. Roman, F.J., Pascaud, X., Martin, B., Vauché, D., Junien, J.-L. JO 1784, a potent and selective ligand for rat and mouse brain σ-sites. J Pharm Pharmacol 1990, 42: 439-40.
16. Wolfe, S.A. Jr., Culp, S.G., De Souza, E.B. σ-Receptor in endocrine organs: Identification, characterization, and autoradiographic localization in rat pituitary, adrenal, testis, and ovary. Endocrinology 1989, 124: 1160-72.
17. Wolfe, S.A. Jr., De Souza, E.B. Sigma and phencyclidine receptors in the brain-endocrine-immune axis. NIDA Res Monogr 1993, 133: 95-123.
18. Moebius, F.F., Striessnig, J., Glossmann, H. The mysteries of a receptors: New family members reveal a role in cholesterol synthesis. Trends Pharmacol Sci 1997, 18: 67-70.
19. 3H]SKF 10,047 binding sites in rat liver. Eur J Pharmacol 1992, 225: 69-74.
20. Ellis, Y., Davies, J.A. The effects of a ligands on the release of glutamate from rat striatal slices. Naunyn-Schmied Arch Pharmacol 1994, 350: 143-8.
21. 1-binding sites for sterol isomerization inhibitors: Evidence for a pharmacological relationship with the yeast sterol C8-C7 isomerase. Br J Pharmacol 1997, 121: 1-6.
22. Su, T.-P., London, E.D., Jaffe, J.H. Steroid binding at a receptors suggests a link between endocrine, nervous, and immune system. Science 1988, 240: 216-21.
23. Meyer, C., Schmieding, K., Falkenstein, E., Wehling, M. Are high-affinity progesterone binding site(s) from porcine liver microsomes members of the a receptor family? Eur J Pharmacol 1998, 347: 293-9.
24. 1-like receptor. J Pharmacol Exp Ther 1998, 284: 553-60.
25. 1 receptor antagonists. Schizophrenia Res 1998, 31: 27-36.
26. Roman, F., Pascaud, X., Duffy, O., Vauche, D., Martin, B., Junien, J.L. Neuropeptide Y and peptide YY interact with rat brain a and PCP binding sites. Eur J Pharmacol 1989, 174: 301-2.
27. 2 receptor in rat brain. Mol Pharmacol 1992, 42(3): 471-9.
28. Contreras, P.C., Gray, N.M., DiMaggio, D.A., Bremer, M.E., Bussom, J.A. Isolation and characterization of an endogenous ligand for the PCP and σ receptors from porcine, rat, and human tissue. NIDA Res Monogr 1993, 133: 207-22.
29. Su, T.-P. Pharmacologic characterizations of σ receptors. NIDA Res Monogr 1993, 133: 41-53.
30. Bergeron, R., Debonnel, G. Effects of low and high doses of selective σ ligands: Further evidence suggesting the existence of different subtypes of sigma receptors. Psychopharmacology 1997, 129: 215-24.
31. Quirion, R., Bowen, W.D., Itzhak, Y., Junien, J.L., Musacchio, J.M., Rothman, R.B., Su, T.-P., Tam, S.W., Taylor, D.P. A proposal for the classification of σ binding sites. Trends Pharmacol Sci 1992, 13: 85-6.
32. 1-binding site. Proc Natl Acad Sci USA 1996, 93: 8072-7.
33. 1 receptor. J Neurochem 1998, 70: 2279-85.
34. Earley, B., Burke, M., Leonard, B.E., Gouret, C.-J., Junien, J.-L. Evidence for an anti-amnesic effect of JO 1784 in the rat: A potent and selective ligand for the σ receptor. Brain Res 1991, 546: 282-6.
35. Debonnel, G., Dryver, E., Lavoie, N. Effect of σ ligands on NMDA receptor function in the bulbectomy model of depression: A behavioural study in the rat. Eur Neuropsychopharmacol 1995, 5(3): Abst P-2-9.
36. Song, C., Earley, B., Leonard, B.E. Effect of chronic pretreatment with the σ ligand JO 1784 on CRF-induced changes in behaviour, neurotransmitter and immunological function in the rat. Neuropsychobiology 1997, 35: 200-4.
37. 3H]acetylcholine release from rat hippocampal slices. Eur J Pharmacol 1991, 200: 343-5.
38. Gronier, B., Debonnel, G. Electrophysiological evidence for the implication of cholecystokinin in the modulation of the N-methyl-D-aspartate response by σ ligands in the rat CA3 dorsal hippocampus. Naunyn-Schmied Arch Pharmacol 1996, 353: 382-90.
39. Earley, B., Canney, M., Clune, B., Caldwell, M., Leonard, B.E., Junien, J.-L. The effects of MK-801, ifenprodil, JO 1784, JO 1994 and JO 1997 on PK 11195 receptor binding, nitric oxide synthase (NO synthase) activity and infant volume in a mouse model of focal cerebral ischaemia. Neurochem Int 1996, 28: 509-21.
40. Earley, B., Canney, M., O'Neill, M., Leonard, B.E., Junien, J.-L. Experimental cerebral ischaemia in mongolian gerbils: Effects of JO 1784 on locomotor activity and ischaemia-induced hippocampal damage. Med Sci Res 1995, 23: 555-9.
41. O'Neill, M., Caldwell, M., Earley, B., Canney, M., O'Halloran, A., Kelly, J., Leonard, B.E., Junien, J.-L. The σ receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischaemia. Eur J Pharmacol 1995, 283: 217-25.
42. O'Connell, A.W., Earley, B., Leonard, B.E. The σ ligrand JO 1784 prevents trimethyltin-induced behavioural and σ-receptor dysfunction in the rat. Pharmacol Toxicol 1996, 78: 296-302.
43. Song, C., Leonard, B.E. Comparison between the effects of σ receptor ligand JO 1784 and neuropeptide Y on immune functions. Eur J Pharmacol 1998, 345: 79-87.
44. Junien, J.L., Gue, M., Bueno, L. Neuropeptide Y and sigma ligand (JO 1784) act through a Gi protein to block the psychological stress and corticotropin-releasing factor-induced colonic motor activation in rats. Neuropharmacology 1991, 30: 1119-24.
45. Yoneda, M., Junien, J.L., Taché, Y. Central action of σ receptor ligand, JO-1784, to suppress CRF-induced inhibition of gastric function in conscious rats. Eur J Pharmacol 1992, 223: 197-9.
46. Gue, M., Junien, J.L., Del Rio, C., Bueno, L. Neuropeptide Y and a ligand (JO 1784) suppress stress-induced colonic motor disturbances in rats through sigma and cholecystokinin receptors. J Pharmacol Exp Ther 1992, 261: 850-5.
47. Gué, M., Gleïzes-Escala, C., Del Rio-Lacheze, C., Junien, J.-L., Bueno, L. Reversal of CRF-and dopamine-induced stimulation of colonic motility by CCK and igmesine (JO 1784) in the rat. Br J Pharmacol 1994, 111: 930-4.
48. Pascaud, X.B., Chovet, M., Soulard, P., Chevalier, E., Roze, C., Junien, J.-L. Effects of a new σ-ligand, JO-1784, on cysteamine ulcers and duodenal alkaline secretion in rats. Gastroenterology 1993, 104: 427-34.
49. Zoski, K., Brandon, R., Akunne, H.C., Heffer, T.G., Pugsley, T.A. The effect of igmesine on monoamine neuronal uptake in the rat. Soc Neurosci Abst 1998, 24(Part 2): Abst 583.15.
50. 1 ligand, igmesine: Effects on monoamine oxidase A and B, and on monoamine uptake and catecholamine synthesis. Soc Neurosci Abst 1998, 24(Part 2): Abst 583.16.
51. 1 ligand, igmesine, on neurotransmitter activity in the rat as assessed by intracerebral microdialysis. Soc Neurosci Abst 1998, 24(Part 2): Abst 583.14.
52. Kinsora, J.J. Jr., Corbin, A.E., Snyder, B.J., Wiley, J.N., Meltzer, L.T., Heffner, T.G. Effects of igmesine in preclinical antidepressant tests. Soc Neurosci Abst 1998, 24(Part 1): Abst 291.3.
53. Debonnel, G., Bergeron, R. Potential implication of sigma ligands and of some neurosteroids in depression. 21st CINP Cong (July 12-16, Glasgow) 1998, Abst SM0503.
54. Fargeau, H., Rivière, P.J.M., Junien, J.L., Chovet, M. Igmesine inhibition of VIP-induced jejunal hypersecretion in rats: Involvement of endogenous somatostatin and nervous pathways. Gastroenterology 1998, 114(4, Part 2): Abst G1500.
55. Theodorou, V., Chovet, M., Fioramonti, J., Bueno, L. Comparative antisecretory effect of loperamide somatostatin and the σ ligand igmesine on IL-1β-induced colonic hypersecretion in rats. Gastroenterology 1998, 114(4, Part 2): Abst G1724.
56. Pande, A.C., Genève, J., Scherrer, B. Igmesine, a novel σ ligand, has antidepressant properties. 21st CINP Cong (July 12-16, Glasgow) 1998, Abst SM0505.
57. Rozé, C., Bruley des Varannes, S., Shi, G., Genève, J., Galmiche, J.P. Inhibition of prostaglandin-induced intestinal secretion by igmesine in healthy volunteers. Gastroenterology 1998, 115: 591-6.
58. JO-1784 development status. Jouveinal SA Company Communication July 27, 1998.
59. Tsujita, R. et al. Pharmacological profile of AZ-21666, a novel antipsychotic drug (1): Biochemical analysis. Jpn J Pharmacol 1997, 73(Suppl.1): Abst P-355.
60. 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines. J Med Chem 1995, 38: 2009-17.
61. 2 binding site. 1. 3-(ω-Aminoalkyl)-1H-indoles. J Med Chem 1995, 38: 1998-2008.
62. Guitart, X., Ballarin, M., Codony, X., Dordal, A., Farré, A.J., Frigola, J., Mercé, R. E-5842. Drugs Fut 1999, 24: in preparation.
63. 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur J Pharmacol 1996, 315: 1-10.